indiaUpdated: Aug 20, 2020 21:55 ISTRussia is looking for a partnership with India for producing Covid-19 vaccine Sputnik V, Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), said on Thursday. Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along with the RDIF. We believe that they are capable of producing the Gamaleya vaccine and it is very important to say that those partnerships to produce the vaccine will enable us to cover the demand that we have,” he said. “We are going to do clinical trials not just in Russia but also in the UAE, Saudi Arabia, probably in Brazil and India. “Vaccines do not contain live human adenoviruses, but human adenovirus vectors, that is, human viruses that cannot multiply in the body and are completely safe,” he said.

Source: Hindustan Times August 20, 2020 16:05 UTC